Citadel Advisors’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
624,758
-2,287,143
| -79% | -$4.78M | ﹤0.01% | 3049 |
|
|
2025
Q1 | $4.96M | Buy |
2,911,901
+2,740,439
| +1,598% | +$4.67M | ﹤0.01% | 1762 |
|
|
2024
Q4 | $866K | Buy |
171,462
+18,318
| +12% | +$92.5K | ﹤0.01% | 3407 |
|
|
2024
Q3 | $833K | Buy |
153,144
+109,242
| +249% | +$594K | ﹤0.01% | 3280 |
|
|
2024
Q2 | $211K | Sell |
43,902
-210,349
| -83% | -$1.01M | ﹤0.01% | 4614 |
|
|
2024
Q1 | $791K | Buy |
254,251
+69,121
| +37% | +$215K | ﹤0.01% | 3438 |
|
|
2023
Q4 | $526K | Sell |
185,130
-93,457
| -34% | -$265K | ﹤0.01% | 3683 |
|
|
2023
Q3 | $816K | Buy |
278,587
+239,498
| +613% | +$702K | ﹤0.01% | 3247 |
|
|
2023
Q2 | $112K | Buy |
+39,089
| New | +$112K | ﹤0.01% | 4691 |
|
|
2023
Q1 | – | Sell |
-510
| Closed | -$1.08K | – | 6184 |
|
|
2022
Q4 | $1.08K | Sell |
510
-168,468
| -100% | -$355K | ﹤0.01% | 5911 |
|
|
2022
Q3 | $551K | Sell |
168,978
-30,605
| -15% | -$99.8K | ﹤0.01% | 3989 |
|
|
2022
Q2 | $640K | Buy |
199,583
+147,415
| +283% | +$473K | ﹤0.01% | 3885 |
|
|
2022
Q1 | $368K | Buy |
52,168
+32,275
| +162% | +$228K | ﹤0.01% | 4748 |
|
|
2021
Q4 | $144K | Buy |
+19,893
| New | +$144K | ﹤0.01% | 5691 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6686 |
|